GV20 Oncotherapy

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1 Broadway Ste 14, Cambridge, Massachuse...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About GV20 Oncotherapy

GV20 Oncotherapy was started by an expert team trained at world-renowned universities. We are devoted to precision medicine development in cancer immuno-oncology. GV20 Oncotherapy has innovative antibody drug discovery and development platforms that integrate cancer genomics, immuno-oncology, and artificial intelligence. We are utilizing our technological advantages to search novel immunotherapy targets, screen fully human anti-tumor antibodies, and identify robust clinical biomarkers.Explore more
GV20 Oncotherapy's Social MediaPopular SearchesGv20 OncotherapySIC Code 87,873NAICS Code 54,541Show more

GV20 Oncotherapy Org Chart

PhoneEmail
Tengfei Xiao, Chief Technology Officer at GV20 Oncotherapy
United States flag for contact location.

Chief Technology Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is GV20 Oncotherapy your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to GV20 Oncotherapy

Compare insights from companies similar to GV20 Oncotherapy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

GV20 Oncotherapy

<$5M
11-50
Private
-
-
Tengfei Xiao, Chief Technology Officer at GV20 Oncotherapy
Tengfei XiaoChief Technology Officer
$7.6M
11-50
Private
-
2008
KM
Kevin McClayResearch & Development Scientist
<$5M
1-10
Private
-
2019
Joseph Murphy, Founder & President at Immunepcs
Joseph MurphyFounder & President
<$5M
11-50
Private
$100M
2020
Jeffrey Kraws, Chief Financial Officer at Syncromune
Jeffrey KrawsChief Financial Officer
<$5M
1-10
Private
-
2009
LP
Lalit PatilQuality Assurance Engineer
<$5M
1-10
Private
-
2007
N/A
<$5M
1-10
Private
-
2019
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

GV20 Oncotherapy is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

GV20 Oncotherapy is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GV20 Oncotherapy.

GV20 Oncotherapy Tech Stack

A closer look at the technologies used by GV20 Oncotherapy

Top Business Services Companies

Frequently Asked Questions Regarding GV20 Oncotherapy

What is GV20 Oncotherapy's official website?
GV20 Oncotherapy's official website is www.gv20therapeutics.com
What is GV20 Oncotherapy's Revenue?
GV20 Oncotherapy's revenue is <$5 Million
What is GV20 Oncotherapy's SIC code?
GV20 Oncotherapy's SIC: 87,873
What is GV20 Oncotherapy's NAICS code?
GV20 Oncotherapy's NAICS: 54,541
How many employees does GV20 Oncotherapy have?
GV20 Oncotherapy has 11-50 employees
What industry does GV20 Oncotherapy belong to?
GV20 Oncotherapy is in the industry of: Business Services, Research & Development
What is GV20 Oncotherapy competition?
GV20 Oncotherapy top competitors include: MedChem Innovations, Fox Chase Chemical Diversity Center, Kemxtree, Syncromune
What technology does GV20 Oncotherapy use?
Some of the popular technologies that GV20 Oncotherapy uses are: Eploy, Engage ATS, Empetus, Voracio
Who is the CTO of GV20 Oncotherapy?
GV20 Oncotherapy's CTO is Tengfei Xiao
What does GV20 Oncotherapy do?

GV20 Oncotherapy was started by an expert team trained at world-renowned universities. We are devoted to precision medicine development in cancer immuno-oncology. GV20 Oncotherapy has innovative antibody drug discovery and development platforms that integrate cancer genomics, immuno-oncology, and artificial intelligence. We are utilizing our techno... logical advantages to search novel immunotherapy targets, screen fully human anti-tumor antibodies, and identify robust clinical biomarkers.Read More

What are GV20 Oncotherapy social media links?
GV20 Oncotherapy Linkedin page
Is GV20 Oncotherapy a public company?
GV20 Oncotherapy is private company therefore does not currently have an official ticker symbol
See more information about GV20 Oncotherapy

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.